[Federal Register Volume 66, Number 136 (Monday, July 16, 2001)]
[Notices]
[Page 37072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-15671]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--RXHUB LLC

    Notice is hereby given that, on May 14, 2001, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), RxHub LLC has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing (1) the identities of the parties and (2) 
the nature and objectives of the venture. The notifications were filed 
for the purpose of invoking the Act's provisions limiting the recovery 
of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
are AdvancePCS, Dallas, TX; Express Scripts, Inc., Maryland Heights, 
MO; and Merck-Medco Managed Care, L.L.C., Franklin Lakes, NJ.
    The nature and objectives of the venture are the development and 
operation of an electronic prescription and information routing service 
for the purpose of facilitating error-free prescription benefit 
communications.

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 01-15671 Filed 7-13-01; 8:45 am]
BILLING CODE 4410-11-M